Recent Finacing
Recent Raise
Hansa Biopharma develops IgG‑cleaving enzyme imlifidase (Idefirix) and a proprietary enzyme platform for transplantation, autoimmune, gene‑therapy, and oncology, running multi‑phase clinical programs from Sweden, Europe, and the U.S.
